Loading…

Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment

Alternative splicing (AS) is an important event that contributes to posttranscriptional gene regulation. This process leads to several mature transcript variants with diverse physiological functions. Indeed, disruption of various aspects of this multistep process, such as cis- or trans- factor alter...

Full description

Saved in:
Bibliographic Details
Published in:Cell death & disease 2021-07, Vol.12 (8), p.752-752, Article 752
Main Authors: Chen, Yanyan, Huang, Mengxi, Liu, Xiaolong, Huang, Yadi, Liu, Chao, Zhu, Jialong, Fu, Gongbo, Lei, Zengjie, Chu, Xiaoyuan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c540t-a206c9c6e254880782a4754ce2197301d78c229278ab2bb1d15eca1f32d82e653
cites cdi_FETCH-LOGICAL-c540t-a206c9c6e254880782a4754ce2197301d78c229278ab2bb1d15eca1f32d82e653
container_end_page 752
container_issue 8
container_start_page 752
container_title Cell death & disease
container_volume 12
creator Chen, Yanyan
Huang, Mengxi
Liu, Xiaolong
Huang, Yadi
Liu, Chao
Zhu, Jialong
Fu, Gongbo
Lei, Zengjie
Chu, Xiaoyuan
description Alternative splicing (AS) is an important event that contributes to posttranscriptional gene regulation. This process leads to several mature transcript variants with diverse physiological functions. Indeed, disruption of various aspects of this multistep process, such as cis- or trans- factor alteration, promotes the progression of colorectal cancer. Therefore, targeting some specific processes of AS may be an effective therapeutic strategy for treating cancer. Here, we provide an overview of the AS events related to colorectal cancer based on research done in the past 5 years. We focus on the mechanisms and functions of variant products of AS that are relevant to malignant hallmarks, with an emphasis on variants with clinical significance. In addition, novel strategies for exploiting the therapeutic value of AS events are discussed.
doi_str_mv 10.1038/s41419-021-04031-w
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_90ceeefbcf9a4f2084068daf9cb42aed</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_90ceeefbcf9a4f2084068daf9cb42aed</doaj_id><sourcerecordid>2557233368</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-a206c9c6e254880782a4754ce2197301d78c229278ab2bb1d15eca1f32d82e653</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhiMEolXpH-CALHHhEvBXEpsD0qrio1IFEoKzNXEmwavEXmxvV_33mE0pLQd8sEeeZ17PyG9VPWf0NaNCvUmSSaZryllNJRWsPjyqTjmVrJZK6cf34pPqPKUtLUsIypv2aXUiZAmV5qeV3cwZo4fsrpGk3eys8xMJI1m-ft4Q54kNc4hoM8zEgrcY3xKPB5JyhIyTw0TGEEneL2UfHEw-JJcI-IHkiJAX9PlZ9WSEOeH57XlWff_w_tvFp_rqy8fLi81VbRtJcw2ctlbbFnlT2qad4iC7RlrkTHeCsqFTlnPNOwU973s2sAYtsFHwQXFsG3FWXa66Q4Ct2UW3QLwxAZw5XoQ4GYjZ2RmNphYRx96OGuTIqZK0VQOM2vaSAw5F692qtdv3Cw62jBFhfiD6MOPdDzOFa6MEl6pVReDVrUAMP_eYsllcsjjP4DHsk-FN03EhxBF9-Q-6DfvyJ_ORahupmZKF4itlY0gp4njXDKPmtyXMaglTLGGOljCHUvTi_hh3JX8MUACxAqmk_ITx79v_kf0F2t7DEg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2556549184</pqid></control><display><type>article</type><title>Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment</title><source>Open Access: PubMed Central</source><source>Access via ProQuest (Open Access)</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Chen, Yanyan ; Huang, Mengxi ; Liu, Xiaolong ; Huang, Yadi ; Liu, Chao ; Zhu, Jialong ; Fu, Gongbo ; Lei, Zengjie ; Chu, Xiaoyuan</creator><creatorcontrib>Chen, Yanyan ; Huang, Mengxi ; Liu, Xiaolong ; Huang, Yadi ; Liu, Chao ; Zhu, Jialong ; Fu, Gongbo ; Lei, Zengjie ; Chu, Xiaoyuan</creatorcontrib><description>Alternative splicing (AS) is an important event that contributes to posttranscriptional gene regulation. This process leads to several mature transcript variants with diverse physiological functions. Indeed, disruption of various aspects of this multistep process, such as cis- or trans- factor alteration, promotes the progression of colorectal cancer. Therefore, targeting some specific processes of AS may be an effective therapeutic strategy for treating cancer. Here, we provide an overview of the AS events related to colorectal cancer based on research done in the past 5 years. We focus on the mechanisms and functions of variant products of AS that are relevant to malignant hallmarks, with an emphasis on variants with clinical significance. In addition, novel strategies for exploiting the therapeutic value of AS events are discussed.</description><identifier>ISSN: 2041-4889</identifier><identifier>EISSN: 2041-4889</identifier><identifier>DOI: 10.1038/s41419-021-04031-w</identifier><identifier>PMID: 34330892</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>38 ; 38/91 ; 631/337 ; 631/67/2324 ; 631/80 ; Alternative splicing ; Alternative Splicing - genetics ; Animals ; Antibodies ; Apoptosis - genetics ; Biochemistry ; Biomedical and Life Sciences ; Cancer ; Cell Biology ; Cell Culture ; Colorectal cancer ; Colorectal carcinoma ; Colorectal Neoplasms - blood supply ; Colorectal Neoplasms - diagnosis ; Colorectal Neoplasms - genetics ; Colorectal Neoplasms - therapy ; Gene regulation ; Humans ; Immunology ; Life Sciences ; Post-transcription ; Protein Processing, Post-Translational ; Review ; Review Article ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; Spliceosomes - metabolism</subject><ispartof>Cell death &amp; disease, 2021-07, Vol.12 (8), p.752-752, Article 752</ispartof><rights>The Author(s) 2021</rights><rights>2021. The Author(s).</rights><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-a206c9c6e254880782a4754ce2197301d78c229278ab2bb1d15eca1f32d82e653</citedby><cites>FETCH-LOGICAL-c540t-a206c9c6e254880782a4754ce2197301d78c229278ab2bb1d15eca1f32d82e653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2556549184/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2556549184?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34330892$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Yanyan</creatorcontrib><creatorcontrib>Huang, Mengxi</creatorcontrib><creatorcontrib>Liu, Xiaolong</creatorcontrib><creatorcontrib>Huang, Yadi</creatorcontrib><creatorcontrib>Liu, Chao</creatorcontrib><creatorcontrib>Zhu, Jialong</creatorcontrib><creatorcontrib>Fu, Gongbo</creatorcontrib><creatorcontrib>Lei, Zengjie</creatorcontrib><creatorcontrib>Chu, Xiaoyuan</creatorcontrib><title>Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment</title><title>Cell death &amp; disease</title><addtitle>Cell Death Dis</addtitle><addtitle>Cell Death Dis</addtitle><description>Alternative splicing (AS) is an important event that contributes to posttranscriptional gene regulation. This process leads to several mature transcript variants with diverse physiological functions. Indeed, disruption of various aspects of this multistep process, such as cis- or trans- factor alteration, promotes the progression of colorectal cancer. Therefore, targeting some specific processes of AS may be an effective therapeutic strategy for treating cancer. Here, we provide an overview of the AS events related to colorectal cancer based on research done in the past 5 years. We focus on the mechanisms and functions of variant products of AS that are relevant to malignant hallmarks, with an emphasis on variants with clinical significance. In addition, novel strategies for exploiting the therapeutic value of AS events are discussed.</description><subject>38</subject><subject>38/91</subject><subject>631/337</subject><subject>631/67/2324</subject><subject>631/80</subject><subject>Alternative splicing</subject><subject>Alternative Splicing - genetics</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Apoptosis - genetics</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Cancer</subject><subject>Cell Biology</subject><subject>Cell Culture</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Colorectal Neoplasms - blood supply</subject><subject>Colorectal Neoplasms - diagnosis</subject><subject>Colorectal Neoplasms - genetics</subject><subject>Colorectal Neoplasms - therapy</subject><subject>Gene regulation</subject><subject>Humans</subject><subject>Immunology</subject><subject>Life Sciences</subject><subject>Post-transcription</subject><subject>Protein Processing, Post-Translational</subject><subject>Review</subject><subject>Review Article</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>Spliceosomes - metabolism</subject><issn>2041-4889</issn><issn>2041-4889</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kk1v1DAQhiMEolXpH-CALHHhEvBXEpsD0qrio1IFEoKzNXEmwavEXmxvV_33mE0pLQd8sEeeZ17PyG9VPWf0NaNCvUmSSaZryllNJRWsPjyqTjmVrJZK6cf34pPqPKUtLUsIypv2aXUiZAmV5qeV3cwZo4fsrpGk3eys8xMJI1m-ft4Q54kNc4hoM8zEgrcY3xKPB5JyhIyTw0TGEEneL2UfHEw-JJcI-IHkiJAX9PlZ9WSEOeH57XlWff_w_tvFp_rqy8fLi81VbRtJcw2ctlbbFnlT2qad4iC7RlrkTHeCsqFTlnPNOwU973s2sAYtsFHwQXFsG3FWXa66Q4Ct2UW3QLwxAZw5XoQ4GYjZ2RmNphYRx96OGuTIqZK0VQOM2vaSAw5F692qtdv3Cw62jBFhfiD6MOPdDzOFa6MEl6pVReDVrUAMP_eYsllcsjjP4DHsk-FN03EhxBF9-Q-6DfvyJ_ORahupmZKF4itlY0gp4njXDKPmtyXMaglTLGGOljCHUvTi_hh3JX8MUACxAqmk_ITx79v_kf0F2t7DEg</recordid><startdate>20210730</startdate><enddate>20210730</enddate><creator>Chen, Yanyan</creator><creator>Huang, Mengxi</creator><creator>Liu, Xiaolong</creator><creator>Huang, Yadi</creator><creator>Liu, Chao</creator><creator>Zhu, Jialong</creator><creator>Fu, Gongbo</creator><creator>Lei, Zengjie</creator><creator>Chu, Xiaoyuan</creator><general>Nature Publishing Group UK</general><general>Springer Nature B.V</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210730</creationdate><title>Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment</title><author>Chen, Yanyan ; Huang, Mengxi ; Liu, Xiaolong ; Huang, Yadi ; Liu, Chao ; Zhu, Jialong ; Fu, Gongbo ; Lei, Zengjie ; Chu, Xiaoyuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-a206c9c6e254880782a4754ce2197301d78c229278ab2bb1d15eca1f32d82e653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>38</topic><topic>38/91</topic><topic>631/337</topic><topic>631/67/2324</topic><topic>631/80</topic><topic>Alternative splicing</topic><topic>Alternative Splicing - genetics</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Apoptosis - genetics</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Cancer</topic><topic>Cell Biology</topic><topic>Cell Culture</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Colorectal Neoplasms - blood supply</topic><topic>Colorectal Neoplasms - diagnosis</topic><topic>Colorectal Neoplasms - genetics</topic><topic>Colorectal Neoplasms - therapy</topic><topic>Gene regulation</topic><topic>Humans</topic><topic>Immunology</topic><topic>Life Sciences</topic><topic>Post-transcription</topic><topic>Protein Processing, Post-Translational</topic><topic>Review</topic><topic>Review Article</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>Spliceosomes - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Yanyan</creatorcontrib><creatorcontrib>Huang, Mengxi</creatorcontrib><creatorcontrib>Liu, Xiaolong</creatorcontrib><creatorcontrib>Huang, Yadi</creatorcontrib><creatorcontrib>Liu, Chao</creatorcontrib><creatorcontrib>Zhu, Jialong</creatorcontrib><creatorcontrib>Fu, Gongbo</creatorcontrib><creatorcontrib>Lei, Zengjie</creatorcontrib><creatorcontrib>Chu, Xiaoyuan</creatorcontrib><collection>Springer Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Science Journals</collection><collection>ProQuest Biological Science Journals</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cell death &amp; disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Yanyan</au><au>Huang, Mengxi</au><au>Liu, Xiaolong</au><au>Huang, Yadi</au><au>Liu, Chao</au><au>Zhu, Jialong</au><au>Fu, Gongbo</au><au>Lei, Zengjie</au><au>Chu, Xiaoyuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment</atitle><jtitle>Cell death &amp; disease</jtitle><stitle>Cell Death Dis</stitle><addtitle>Cell Death Dis</addtitle><date>2021-07-30</date><risdate>2021</risdate><volume>12</volume><issue>8</issue><spage>752</spage><epage>752</epage><pages>752-752</pages><artnum>752</artnum><issn>2041-4889</issn><eissn>2041-4889</eissn><abstract>Alternative splicing (AS) is an important event that contributes to posttranscriptional gene regulation. This process leads to several mature transcript variants with diverse physiological functions. Indeed, disruption of various aspects of this multistep process, such as cis- or trans- factor alteration, promotes the progression of colorectal cancer. Therefore, targeting some specific processes of AS may be an effective therapeutic strategy for treating cancer. Here, we provide an overview of the AS events related to colorectal cancer based on research done in the past 5 years. We focus on the mechanisms and functions of variant products of AS that are relevant to malignant hallmarks, with an emphasis on variants with clinical significance. In addition, novel strategies for exploiting the therapeutic value of AS events are discussed.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>34330892</pmid><doi>10.1038/s41419-021-04031-w</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2041-4889
ispartof Cell death & disease, 2021-07, Vol.12 (8), p.752-752, Article 752
issn 2041-4889
2041-4889
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_90ceeefbcf9a4f2084068daf9cb42aed
source Open Access: PubMed Central; Access via ProQuest (Open Access); Springer Nature - nature.com Journals - Fully Open Access
subjects 38
38/91
631/337
631/67/2324
631/80
Alternative splicing
Alternative Splicing - genetics
Animals
Antibodies
Apoptosis - genetics
Biochemistry
Biomedical and Life Sciences
Cancer
Cell Biology
Cell Culture
Colorectal cancer
Colorectal carcinoma
Colorectal Neoplasms - blood supply
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - genetics
Colorectal Neoplasms - therapy
Gene regulation
Humans
Immunology
Life Sciences
Post-transcription
Protein Processing, Post-Translational
Review
Review Article
RNA, Messenger - genetics
RNA, Messenger - metabolism
Spliceosomes - metabolism
title Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T09%3A39%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alternative%20splicing%20of%20mRNA%20in%20colorectal%20cancer:%20new%20strategies%20for%20tumor%20diagnosis%20and%20treatment&rft.jtitle=Cell%20death%20&%20disease&rft.au=Chen,%20Yanyan&rft.date=2021-07-30&rft.volume=12&rft.issue=8&rft.spage=752&rft.epage=752&rft.pages=752-752&rft.artnum=752&rft.issn=2041-4889&rft.eissn=2041-4889&rft_id=info:doi/10.1038/s41419-021-04031-w&rft_dat=%3Cproquest_doaj_%3E2557233368%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c540t-a206c9c6e254880782a4754ce2197301d78c229278ab2bb1d15eca1f32d82e653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2556549184&rft_id=info:pmid/34330892&rfr_iscdi=true